What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer

OBJECTIVE: To identify what matters to clinicians and patients when discussing cancer medicines’ impact on health-related quality of life (HRQoL). METHODS: A framework of HRQoL domain/domain elements was developed, informed by analysis of published patient reported outcome measures (PROMs), applicab...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunlop, Emma, Ferguson, Aimee, Mueller, Tanja, Baillie, Kelly, Clarke, Julie, Laskey, Jennifer, Kurdi, Amanj, Wu, Olivia, Jones, Rob, Glen, Hilary, Bennie, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857102/
https://www.ncbi.nlm.nih.gov/pubmed/34878587
http://dx.doi.org/10.1007/s00520-021-06724-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857102/
https://www.ncbi.nlm.nih.gov/pubmed/34878587
http://dx.doi.org/10.1007/s00520-021-06724-6

Ejemplares similares